CVRx Closes $29.6m Financing

CVRx, a private medical device company, has completed a financing round totaling $29.6 million. CVRx plans to use the funding for advancing its clinical trials and expanding its international commercial activities. New Enterprise Associates and Johnson & Johnson Development Corporation were the co-lead investors. Other participants in this round included existing investors BBT Fund L.P. and SightLine Partners.

11 July 2013•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail